
Careers article - November 16, 2020
Hey there Carlos de Sousa, new CEO of Ultimovacs
In June this year, Carlos de Sousa commenced his role as Chief Executive Officer of Norwegian Ultimovacs, a pharmaceutical company developing novel immunotherapies against cancer. Congratulations on your new position! What made you say yes, or apply for the job? “Ultimovacs presented a unique opportunity with its UV1 universal vaccine approach in oncology and it […]